Clinical Trials Directory

Trials / Unknown

UnknownNCT03410160

Predisposing Factors for the Incidence of Adrenal Crisis

Predisposing Factors for the Incidence of Adrenal Crisis in Chronic Adrenal Insufficiency

Status
Unknown
Phase
Study type
Observational
Enrollment
71 (estimated)
Sponsor
Wuerzburg University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Within this clinical study patients with chronic adrenal insufficiency will be investigated by clinical and biochemical examination as well as questionnaire to identify predisposing factors for adrenal crisis.

Detailed description

Patients with chronic adrenal insufficiency (AI) are at risk of suffering from life-threatening adrenal crisis (AC), despite established hormone replacement therapies and patient education. Recent retrospective analyses observed different risk factors for AC, e.g. primary AI and comorbidities. Furthermore, patients that already experienced an AC seem to have an increased risk to develop further AC. The aim of the study is to evaluate potential risk factors/predisposing factors for AC in patients with chronic primary and secondary AI (PAI/SAI). Patients with chronic AI are assessed by clinical and biochemical examination and questionnaire to evaluate the quality of hormone replacement therapy with glucocorticoids, education status, cortisol-metabolism, catecholamine deficit, chronic inflammation and variations of the glucocorticoid receptor. AI patients with a high frequency of AC will be compared to matched controls (age, sex and cause of AI) with no AC or a low frequency of AC in the past.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTClinical and biochemical examination.Patients with chronic adrenal insufficiency were assessed by clinical and biochemical examination as well as questionnaire to evaluate the quality of hormone replacement therapy with glucocorticoids, education status, cortisol-metabolism, catecholamine deficit, chronic inflammation and variations of the glucocorticoid receptor.

Timeline

Start date
2015-11-01
Primary completion
2018-06-01
Completion
2019-12-01
First posted
2018-01-25
Last updated
2019-10-14

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT03410160. Inclusion in this directory is not an endorsement.